AI MARKET SCANNING

Savara Inc

🏛️ NASDAQ 📁 Health Technology 🏭 Pharmaceuticals Major
AVG HISTORICAL GAP +1.18%
MAX GAP RECORD +7.18%
🔒 PRO INSTITUTIONAL AI PREDICTIVE WIN RATE
94.2%
REVEAL PRO DIRECTION ⚡

SENTINEL HISTORICAL GAP VIEWER

// $SVRA
📊 1-YEAR TIMELINE (GAPS PLOTTED) 🔮 SIMULATE SETUP 🔒
Bullish Opening Gap Bearish Opening Gap T-1 Close Baseline

CATALYSTS & GAP HISTORY

Aug 11, 2026 Earnings Release 2026-08-11 (AFTER CLOSE)
+6.10%
Mar 13, 2026 Earnings Release 2026-03-13 (BEFORE OPEN)
+0.00%
Nov 12, 2025 Earnings Release 2025-11-12 (AFTER CLOSE)
+0.49%
Aug 13, 2025 Earnings Release 2025-08-13 (BEFORE OPEN)
-1.94%
May 13, 2025 Earnings Release 2025-05-13 (AFTER CLOSE)
-0.67%
Mar 27, 2025 Earnings Release 2025-03-27 (BEFORE OPEN)
-0.74%
Nov 12, 2024 Earnings Release 2024-11-12 (BEFORE OPEN)
+1.72%
Aug 12, 2024 Earnings Release 2024-08-12 (AFTER CLOSE)
+2.44%

VOLATILITY & GAP BIAS

AVG GAP MOVE 2.2%
Bullish Gaps (5)
Bearish Gaps (2)
Neutral / Flat (5)

QUANTITATIVE LIVE RADAR BLOTTER

Algorithmic execution stream for $SVRA

EXECUTIONS1 LOGS
STATUS🔒 ENCRYPTED
Execution Date Strategy & Setup Direction Execution Range Hold Time Net PnL
2026-10-29 🔒 PRO RADAR ••• x• $•••.•• → $•••.•• 1603m +4.42%
🔒 Real-Time Strategy Telemetry Protected

Exact execution levels, Trailing Stops, and live bot signals are reserved for PRO members.

UNLOCK LIVE RADAR ⚡

📖 Intelligence Summary

Savara, Inc. is a clinical-stage pharmaceutical company, which engages in the development and commercialization of novel therapies for the treatment of serious or life-threatening rare respiratory diseases. Its program includes molgramostim, which is an inhaled formulation of recombinant human GM-CSF and being developed for the treatment of autoimmune pulmonary alveolar…

NEXT UPCOMING PREDICTIVE SIGNAL
STRONG BUY / TARGET +35%
🔓 REVEAL AI SIGNAL & TARGETS ↗